Cardinal Health, Inc. (CAH) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Distribution
Cardinal Health, Inc. (CAH) Profile & Business Summary
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Key Information
| Ticker | CAH |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.cardinalhealth.com |
Market Trend Overview for CAH
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-13 (ET)
As of 2026-07-13, CAH is moving sideways without a clear direction. Over the longer term, the trend remains bullish.
CAH last closed at 233.66. The price is about 0.3 ATR below its recent average price (235.36), and the market is currently in a sideways market without a clear direction. Price at 233.66 is moving between minor support near 233.00 and minor resistance near 243.21. Direction remains unclear. View Support & Resistance from Options
The market is moving sideways, with no clear direction. Both upside and downside risks remain in play.
Trend score: 35 out of 100. Overall alignment is unclear. The market is currently in a sideways market without a clear direction. The longer-term trend is still positive, but short-term signals are not yet confirming it.
A key downside risk boundary is near 213.55. If price falls below this area, the current structure would likely weaken further.
A systematic trend-activation signal was most recently triggered on 2026-06-05, reflecting a technical shift toward positive directional alignment.
[2026-06-29] Price moved quickly and looked strong, but participation was limited.
Recent bars show mixed price behavior without a clear shift in structural quality or efficiency.
Some late-day positioning was observed, but it lacked strong overnight commitment.
The model sees a bearish edge, but still treats it as a selective downside setup rather than an aggressive downside call.
Up probability is only 40.6%, with predictability at 56% and agreement at 88%. Reversal risk is 15%, while reward/risk stands at -0.23. That suggests downside pressure is present, while the setup still remains selective rather than extreme.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is only slightly below the recent estimated cost basis of 234.74. Price is in the lower half of the main cost band (232.69 to 236.24), so price support and pullback behavior matter more than immediate upside follow-through. The higher up selling area sits around 236.74 to 240.29, so rebounds may begin to slow as price pushes into that zone. Roughly 74% of recent positioning remains under water, so rebound attempts can still run into supply from trapped holders. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the main question is whether rebounds remain healthy enough to reach and absorb the higher overhead supply zone.